Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IOngoingDec 27, 2023THE ROCKMarketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with Sildenafil an ingredient found in an FDA approved product for the treatment of...Noah's Wholesale LLC · D-0158-2024Class IIOngoingDec 27, 2023NYSTATIN 150 MULabeling: Label Error on Declared Strength: Assay value on the label is incorrect.Fagron, Inc · D-0157-2024Class IIOngoingDec 27, 2023NYSTATIN 2 BULabeling: Label Error on Declared Strength: Assay value on the label is incorrect.Fagron, Inc · D-0156-2024Class IIOngoingDec 27, 2023NYSTATIN 500 MULabeling: Label Error on Declared Strength: Assay value on the label is incorrect.Fagron, Inc · D-0155-2024Class IIOngoingDec 27, 2023NYSTATIN 5BULabeling: Label Error on Declared Strength: Assay value on the label is incorrect.Fagron, Inc · D-0154-2024Class ITerminatedDec 27, 2023Phenytoin Oral SuspensionFailed Content Uniformity SpecificationsThe Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories · D-0153-2024Class IIOngoingDec 27, 2023Selenium Sulfide 2.25% ShampooCGMP Deviations: Stability data does not support expiry date.Private Label Partners, Inc. · D-0152-2024Class ICompletedDec 27, 2023TING 2% Miconazole Nitrate Athlete's Foot Spray Antifungal Spray PowderChemical Contamination; presence of benzene.Insight Pharmaceuticals Corporation · D-0151-2024Class IITerminatedDec 20, 2023Liothyronine Sodium TabletsFailed Impurities/Degradation SpecificationsSun Pharmaceutical Industries Inc · D-0150-2024Class IIICompletedDec 20, 2023VotrientFailed Dissolution SpecificationsSiegfried Barbera, SL · D-0149-2024Class IITerminatedDec 20, 2023Penicillamine Tablets USP 250 mgFailed Dissolution SpecificationsLupin Pharmaceuticals Inc. · D-0148-2024Class IICompletedDec 13, 2023ROPivacaine HCl 0.2% PF in Sodium Chloride 1STAQ Pharma Inc. received consumer complaints related to leaking bags and other potential bag concerns. Upon investigation, they determine the source of the issue was...STAQ Pharma, Inc. · D-0147-2024Class IICompletedDec 13, 2023Ondansetron InjectionFailed pH SpecificationsBaxter Healthcare Corporation · D-0146-2024Class IOngoingDec 13, 2023SANDIMMUNE Oral SolutionCrystallization: bottles of Sandimmune Oral Solution were determined to contain crystalsNovartis Pharmaceuticals Corporation · D-0144-2024Class IIOngoingDec 13, 2023KinderMed INFANTS' PAIN & FEVER AcetaminophenFailed Impurities/Degradation SpecificationsKinder Farms LLC · D-0143-2024Class IIOngoingDec 13, 2023KinderMed KIDS' PAIN & FEVER AcetaminophenFailed Impurities/Degradation SpecificationsKinder Farms LLC · D-0142-2024Class IICompletedDec 13, 2023ceFAZolin sodium in Sterile Water for injectionLack of assurance of sterility.Wells Pharma of Houston LLC · D-0141-2024Class IIITerminatedDec 13, 2023LET GelProduct Mix-up: Incorrect Product FormulationRight Value Drug Stores, LLC dba Carie Boyd's Prescription Shop · D-0140-2024Class IIOngoingDec 13, 2023Trospium Chloride Extended-Release CapsulesFailed Tablets/Capsules specifications; missing/broken/extra tablets within the capsulesPadagis US LLC · D-0139-2024Class IOngoingDec 13, 2023Dr. Ergin's SugarMDMARKETED WITHOUT AN APPROVED NDA/ANDA: Product found to be tainted with metformin and glyburideSugarmds LLC · D-0138-2024Class IIITerminatedDec 13, 2023buPROPion Hydrochloride Extended-Release TabletsFailed Dissolution SpecificationsSun Pharmaceutical Industries Inc · D-0137-2024Class IOngoingDec 6, 2023Kuka Flex Forte capletsMarketed Without an Approved NDA/ANDA: products found to contain undeclared diclofenac.Botanical Be · D-0226-2024Class IOngoingDec 6, 2023Reumo Flex capletsMarketed Without an Approved NDA/ANDA: products found to contain undeclared diclofenac.Botanical Be · D-0225-2024Class IOngoingDec 6, 2023Artri King Reforzado con Origa y Omega 3 tabletsMarketed Without an Approved NDA/ANDA: products found to contain undeclared diclofenac.Botanical Be · D-0224-2024Class ITerminatedDec 6, 2023VITRAKVIMicrobial Contamination of Non-Sterile Products: microbial contamination identified as Penicillium brevicompactum observed during routine ongoing stability testingBayer Healthcare Pharmaceuticals Inc. · D-0145-2024Class IITerminatedDec 6, 2023PAROXETINE tabletsFailed Impurities/Degradation Specifications-Manufacturer Apotex Inc. recalling lots due to Out of specification results for the excipient Amadori Glucose adduct of...Golden State Medical Supply Inc. · D-0130-2024Class IITerminatedDec 6, 2023PAROXETINE tabletsFailed Impurities/Degradation Specifications-Manufacturer Apotex Inc. recalling lots due to Out of specification results for the excipient Amadori Glucose adduct of...Golden State Medical Supply Inc. · D-0129-2024Class IITerminatedDec 6, 2023PAROXETINE tabletsFailed Impurities/Degradation Specifications-Manufacturer Apotex Inc. recalling lots due to Out of specification results for the excipient Amadori Glucose adduct of...Golden State Medical Supply Inc. · D-0128-2024Class IIITerminatedDec 6, 2023Testosterone GelOOS for viscosityTeva Pharmaceuticals USA, Inc · D-0127-2024Class IIITerminatedDec 6, 2023Aminocaproic Acid Oral SolutionFailed Excipient Specifications: high content of ethylene glycol (EG)VistaPharm LLC · D-0126-2024Class IIIOngoingDec 6, 2023Tropicamide 1%Labeling: Label Mix-Up: The label of a dropper bottle mistakenly states the container is a 0.5mL single-use syringe instead of a 5 mL dropperFagron Compounding Services · D-0125-2024Class IIOngoingDec 6, 2023Naproxen TabletsLabeling: Label Mix-Up-Indomethacin bottles may be labeled as NaproxenGlenmark Pharmaceuticals Inc., USA · D-0124-2024Class IIOngoingDec 6, 2023Indomethacin 25mg CapsulesLabeling: Label Mix-Up-Indomethacin bottles may be labeled as NaproxenGlenmark Pharmaceuticals Inc., USA · D-0123-2024Class IIOngoingDec 6, 2023Paroxetine Hydrochloride Tablets USPFailed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of ParoxetineApotex Corp. · D-0122-2024Class IIOngoingDec 6, 2023Paroxetine Hydrochloride Tablets USPFailed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of ParoxetineApotex Corp. · D-0121-2024Class IIOngoingDec 6, 2023Paroxetine Hydrochloride Tablets USPFailed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of ParoxetineApotex Corp. · D-0120-2024Class IIOngoingDec 6, 2023Paroxetine Hydrochloride Tablets USPFailed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of ParoxetineApotex Corp. · D-0119-2024Class IOngoingNov 29, 2023LEADER brand Lubricant Eye DropsNon-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.Cardinal Health Inc. · D-0136-2024Class IOngoingNov 29, 2023LEADER brand Dry Eye ReliefNon-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.Cardinal Health Inc. · D-0135-2024Class IOngoingNov 29, 2023LEADER brand Lubricant Eye DropsNon-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling at the manufacturing facility.Cardinal Health Inc. · D-0134-2024

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.